These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7407791)

  • 1. Designing for nonparametric Bayesian survival analysis using historical controls.
    Van Ryzin J
    Cancer Treat Rep; 1980; 64(2-3):503-6. PubMed ID: 7407791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian monitoring of clinical trials with failure-time endpoints.
    Rosner GL
    Biometrics; 2005 Mar; 61(1):239-45. PubMed ID: 15737099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian approach to bioequivalence for the 2 x 2 changeover design.
    Selwyn MR; Dempster AP; Hall NR
    Biometrics; 1981 Mar; 37(1):11-21. PubMed ID: 7018605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian sample size for exploratory clinical trials incorporating historical data.
    Whitehead J; Valdés-Márquez E; Johnson P; Graham G
    Stat Med; 2008 Jun; 27(13):2307-27. PubMed ID: 18069728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Bayesian sample size determination in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2008 Jun; 27(13):2290-306. PubMed ID: 18205170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confidence intervals for a ratio of two independent binomial proportions.
    Price RM; Bonett DG
    Stat Med; 2008 Nov; 27(26):5497-508. PubMed ID: 18781560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for incorporating historical controls into a meta-analysis.
    Begg CB; Pilote L
    Biometrics; 1991 Sep; 47(3):899-906. PubMed ID: 1742445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A semiparametric Bayesian approach to the random effects model.
    Kleinman KP; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.
    Warn DE; Thompson SG; Spiegelhalter DJ
    Stat Med; 2002 Jun; 21(11):1601-23. PubMed ID: 12111922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian clinical trials: no more excuses.
    Gönen M
    Clin Trials; 2009 Jun; 6(3):203-4. PubMed ID: 19528129
    [No Abstract]   [Full Text] [Related]  

  • 15. Bayesian model selection: analysis of a survival model with a surviving fraction.
    Seltman H; Greenhouse J; Wasserman L
    Stat Med; 2001 Jun; 20(11):1681-91. PubMed ID: 11391695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling overdispersion in longitudinal count data in clinical trials with application to epileptic data.
    Fotouhi AR
    Contemp Clin Trials; 2008 Jul; 29(4):547-54. PubMed ID: 18308644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting potential safety issues in clinical trials by Bayesian screening.
    Gould AL
    Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A covariate adjusted two-stage allocation design for binary responses in randomized clinical trials.
    Bandyopadhyay U; Biswas A; Bhattacharya R
    Stat Med; 2007 Oct; 26(24):4386-99. PubMed ID: 17348082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequentist properties of Bayesian posterior probabilities of phylogenetic trees under simple and complex substitution models.
    Huelsenbeck J; Rannala B
    Syst Biol; 2004 Dec; 53(6):904-13. PubMed ID: 15764559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.